ENT-C225

CAS No. 2919962-53-9

ENT-C225( —— )

Catalog No. M36522 CAS No. 2919962-53-9

ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ENT-C225
  • Note
    Research use only, not for human use.
  • Brief Description
    ENT-C225 is a potent TrkB neurotrophin receptor (TrkBR) activator with neuroprotective activity for the study of Alzheimer's disease and Parkinson's disease.
  • Description
    ENT-C225 is an effective activator of TrkB neurotrophin receptor. ENT-C225 has high effect on activating TrkB receptor (TrkBR), and has good physicochemical properties and neuroprotective properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    Trk Receptor
  • Recptor
    Trk receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2919962-53-9
  • Formula Weight
    488.62
  • Molecular Formula
    C26H40N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NCCO)C=1C=C(C=C(C1)C(=O)NCC2CCN(CC2)CC3CCCCC3)C(=O)NCCO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Antonijevic M, et al. Design, synthesis and biological characterization of novel activators of the TrkB neurotrophin receptor. Eur J Med Chem. 2023 Feb 15;248:115111.?
molnova catalog
related products
  • AZ-23

    AZ-23 is an inhibitor of ATP-competitive and Trk kinase A/B/C.

  • GZ389988

    GZ389988 (GZ-389988) is a novel potent, selective, locally delivered TrkA inhibitor for the treatment osteoarthritis; shows similar IC50 values for TrkA, TrkB and TrkC, and the growth factor receptor cFMS (CSF1R).

  • LM22A-4

    LM22A-4 is a brain-derived neurotrophic factor (BDNF) mimetic and agonist of the receptor tropomyosin-related kinase B (TrkB;?IC50 : 47 nM in a fluorescence anisotropy assay).